Baxdrostat reduces blood pressure in previously treatment-resistant hypertension
1. Compared to placebo, baxdrostat showed a dose-dependent reduction in blood pressure in patients with treatment-resistant hypertension. 2. Baxdrostat was ...
1. Compared to placebo, baxdrostat showed a dose-dependent reduction in blood pressure in patients with treatment-resistant hypertension. 2. Baxdrostat was ...
Click here to read this study in NEJM
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.